SCHEMBL2250478

SCHEMBL2250478

O=C1C[N]CCN1c1ccc(F)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 17/20 0.51
▸ MEN1 O00255 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ CASP6 P55212 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2256178 0.78 P2RX7 (0.42) P2RX7
SCHEMBL20103445 0.75 P2RX7 (0.52) P2RX7MEN1GAACASP6KMT2A
SCHEMBL3654179 0.75 P2RX7 (0.52) P2RX7MEN1GAACASP6KMT2A
SCHEMBL20103179 0.72 HTR1A (0.48) P2RX7
SCHEMBL20205261 0.69 P2RX7 (0.45) P2RX7MEN1GAACASP6KMT2A
SCHEMBL20103153 0.69 P2RX7 (0.45) P2RX7MEN1GAACASP6KMT2A
SCHEMBL3651018 0.68 P2RX7 (1.00) P2RX7
SCHEMBL2248234 0.68 ALDH1A1 (0.45) P2RX7MEN1GAAKMT2A
SCHEMBL2253286 0.68 BPTF (0.44) —
SCHEMBL4328191 0.68 P2RX7 (0.47) P2RX7MEN1GAACASP6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354413-B2 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) Istituto di Ricerche di Biologia Molecolare P. Angeletti, S.R.L. (IT) 2013-01-15 — — US disclosed
US-20110207720-A1 QUINOLIN-4-ONE AND 4-OXODIHYRDOCINNOLINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.R.L. (IT) 2011-08-25 — — US disclosed
EP-2193121-A1 QUINOLIN-4-ONE AND 4-OXODIHYDROCINNOLINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. (IT) 2010-06-09 — — EP disclosed
WO-2009027730-A1 QUINOLIN-4-ONE AND 4-OXODIHYDROCINNOLINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2009-03-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207720-A1 QUINOLIN-4-ONE AND 4-OXODIHYRDOCINNOLINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE (PARP) PARP1, PARP2, PARP11 P2RX7 902/4885MEN1 2511/4885GAA 1856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback